News

Hidden pads up their sleeves because of a lack of appropriate binsWorn traditional pads for too long to the point they leaked ...
Rocky Shore Gold Ltd. (the "Company") (CSE: RSG) is pleased to announce that a fully permitted summer exploration program has ...
VANCOUVER, BC / ACCESS Newswire / June 24, 2025 / North Shore Uranium Ltd. (TSXV:NSU) ("North Shore" or the "Company") is pleased to announce that on June 23, 2025, it signed a binding term sheet (the ...
Catalog Kings Invests in Inkjet as Part of Go-forward Strategy RAMSEY. NJ / ACCESS Newswire / June 24, 2025 / Konica Minolta Business Solutions U.S.A., Inc. (Konica Minolta) is pleased to announce Cat ...
NORTHAMPTON, MA / ACCESS Newswire / June 24, 2025 / Despite widely publicized efforts by the Trump administration and certain Republican-led state governments ...
NORTHAMPTON, MA / ACCESS Newswire / June 24, 2025 / As part of its global mission to achieve carbon neutrality by 2023 (scope 1 and scope 2 emissions), Rockwell Automation recognizes the need for a st ...
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive ...
Jersey City, New Jersey--(Newsfile Corp. - June 24, 2025) - EQUATOR Beverage Company (OTCQB: MOJO), maker of MOJO Energy and MOJO Coconut Water premium functional beverages, today announced that its ...
System Sales Increased 3.5% Year-over-Year to RMB376.3 Million 5.9% Improvement in Company Owned and Operated Store Contribution Margin 25.1 Million Registered Loyalty Club Members at Quarter-End,Repr ...
Comprehensive restructuring eliminates the potential issuance of up to 1.5 billion shares of common stock Plus Therapeutics files a request to withdraw the related resale registration statement with ...
Transaction Follows Completion of Comprehensive Strategic Review by Special Committee of the Board to Maximize Shareholder Value Farmingdale, NY, June 24, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc.
CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for ...